JP2022031717A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022031717A5 JP2022031717A5 JP2021184435A JP2021184435A JP2022031717A5 JP 2022031717 A5 JP2022031717 A5 JP 2022031717A5 JP 2021184435 A JP2021184435 A JP 2021184435A JP 2021184435 A JP2021184435 A JP 2021184435A JP 2022031717 A5 JP2022031717 A5 JP 2022031717A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- reaction mixture
- reaction
- phase
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 25
- 238000000034 method Methods 0.000 claims 12
- 239000011541 reaction mixture Substances 0.000 claims 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 9
- 239000012071 phase Substances 0.000 claims 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 5
- 239000008346 aqueous phase Substances 0.000 claims 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 238000001816 cooling Methods 0.000 claims 3
- 239000013078 crystal Substances 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- -1 acetate ester Chemical class 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 229910052763 palladium Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023202330A JP7688098B2 (ja) | 2014-12-19 | 2023-11-30 | オキサチアジン様化合物を作製する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094580P | 2014-12-19 | 2014-12-19 | |
| US62/094,580 | 2014-12-19 | ||
| JP2019206621A JP7030093B2 (ja) | 2014-12-19 | 2019-11-15 | オキサチアジン様化合物を作製する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019206621A Division JP7030093B2 (ja) | 2014-12-19 | 2019-11-15 | オキサチアジン様化合物を作製する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023202330A Division JP7688098B2 (ja) | 2014-12-19 | 2023-11-30 | オキサチアジン様化合物を作製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022031717A JP2022031717A (ja) | 2022-02-22 |
| JP2022031717A5 true JP2022031717A5 (enExample) | 2022-04-28 |
| JP7449913B2 JP7449913B2 (ja) | 2024-03-14 |
Family
ID=55077556
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017551388A Active JP6746605B2 (ja) | 2014-12-19 | 2015-12-17 | オキサチアジン様化合物を作製する方法 |
| JP2019206621A Active JP7030093B2 (ja) | 2014-12-19 | 2019-11-15 | オキサチアジン様化合物を作製する方法 |
| JP2021184435A Active JP7449913B2 (ja) | 2014-12-19 | 2021-11-12 | オキサチアジン様化合物を作製する方法 |
| JP2023202330A Active JP7688098B2 (ja) | 2014-12-19 | 2023-11-30 | オキサチアジン様化合物を作製する方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017551388A Active JP6746605B2 (ja) | 2014-12-19 | 2015-12-17 | オキサチアジン様化合物を作製する方法 |
| JP2019206621A Active JP7030093B2 (ja) | 2014-12-19 | 2019-11-15 | オキサチアジン様化合物を作製する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023202330A Active JP7688098B2 (ja) | 2014-12-19 | 2023-11-30 | オキサチアジン様化合物を作製する方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10392355B2 (enExample) |
| EP (2) | EP4011871A3 (enExample) |
| JP (4) | JP6746605B2 (enExample) |
| KR (1) | KR102594322B1 (enExample) |
| CN (3) | CN107257786B (enExample) |
| AU (2) | AU2015365348B2 (enExample) |
| CA (1) | CA2971570A1 (enExample) |
| CY (1) | CY1125047T1 (enExample) |
| DK (1) | DK3233813T3 (enExample) |
| ES (1) | ES2907592T3 (enExample) |
| HR (1) | HRP20220313T1 (enExample) |
| HU (1) | HUE058257T2 (enExample) |
| IL (1) | IL252912B (enExample) |
| LT (1) | LT3233813T (enExample) |
| MX (2) | MX392353B (enExample) |
| PL (1) | PL3233813T3 (enExample) |
| PT (1) | PT3233813T (enExample) |
| RS (1) | RS62955B1 (enExample) |
| SI (1) | SI3233813T1 (enExample) |
| SM (1) | SMT202200091T1 (enExample) |
| WO (1) | WO2016098054A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11591302B2 (en) * | 2014-12-19 | 2023-02-28 | Geistlich Pharm A Ag | Processes for preparing oxathiazin-like compounds |
| ES2907592T3 (es) * | 2014-12-19 | 2022-04-25 | Geistlich Pharma Ag | Procesos para preparar compuestos de tipo oxatiazina |
| EP3440064B1 (en) * | 2016-04-07 | 2020-05-13 | Geistlich Pharma AG | Process for preparing oxathiazin-like compounds |
| WO2018155706A1 (ja) * | 2017-02-27 | 2018-08-30 | 株式会社シード探索研究所 | 抗真菌組成物 |
| CN109602744A (zh) * | 2018-12-13 | 2019-04-12 | 中国人民解放军总医院 | 荜茇酰胺在制备抗菌消炎药物中的应用 |
| US12514847B2 (en) | 2019-05-22 | 2026-01-06 | Geistlich Pharma Ag | Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine release |
| WO2020234829A1 (en) * | 2019-05-22 | 2020-11-26 | Geistlich Pharma Ag | Methods and compositions for inhibiting gapdh |
| WO2020234828A1 (en) * | 2019-05-22 | 2020-11-26 | Geistlich Pharma Ag | Oxathiazin compounds for inhibiting gapdh |
| CN111617086A (zh) * | 2020-07-06 | 2020-09-04 | 长春迈灵生物工程有限公司 | 牛磺罗定在制备抗hpv病毒药物中的应用 |
| CN111671758A (zh) * | 2020-07-06 | 2020-09-18 | 长春迈灵生物工程有限公司 | 牛磺罗定在制备抗hiv病毒药物中的应用 |
| JP7752675B2 (ja) * | 2020-07-06 | 2025-10-10 | アカデミー オブ ミリタリー メディカル サイエンシズ | ウイルスに対するタウロリジンの使用 |
| IL307990A (en) * | 2021-04-29 | 2023-12-01 | Geistlich Pharma Ag | Antimicrobial and anticancer agents |
| CN118724762A (zh) * | 2024-06-24 | 2024-10-01 | 湖南增达生物科技有限公司 | 一种牛磺酸的制备新工艺 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1160443B (de) | 1961-11-30 | 1964-01-02 | Hoechst Ag | Verfahren zur Herstellung von Tetrahydro-oxathiazin-dioxyden |
| GB1124285A (en) * | 1964-10-06 | 1968-08-21 | Geistlich Soehne Ag | Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them |
| DE1234988B (de) | 1964-11-28 | 1967-02-23 | Bayer Ag | Verfahren zur Herstellung von Copolymerisaten des Trioxans |
| DK167393B1 (da) * | 1985-12-30 | 1993-10-25 | Roussel Uclaf | 1-sulfonyl-2-oxo-pyrrolidinderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf |
| GB8617482D0 (en) | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
| IT1296926B1 (it) * | 1997-12-05 | 1999-08-03 | Zambon Spa | Procedimento per la preparazione di composti ad attivita' antimicotica |
| WO2006033446A1 (en) * | 2004-09-21 | 2006-03-30 | Astellas Pharma Inc. | Aminoalcohol derivatives |
| US20080275032A1 (en) | 2006-12-29 | 2008-11-06 | Yuefen Zhou | Pyridazinone compounds |
| JP2008222659A (ja) | 2007-03-14 | 2008-09-25 | Asahi Kasei Corp | スルホンアミド化合物の製造方法 |
| TW200911245A (en) * | 2007-06-07 | 2009-03-16 | Astellas Pharma Inc | Pyridone derivatives |
| US8088824B2 (en) | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
| US20120142676A1 (en) * | 2010-08-18 | 2012-06-07 | Gaik-Lean Chee | Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules |
| EP2643308B1 (en) * | 2010-11-23 | 2016-08-17 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the preparation of taurolidine and its intermediates thereof |
| ES2644870T3 (es) * | 2012-06-18 | 2017-11-30 | Geistlich Pharma Ag | Derivados de oxatiazina como agentes antibacterianos y anticancerígenos |
| ES2907592T3 (es) | 2014-12-19 | 2022-04-25 | Geistlich Pharma Ag | Procesos para preparar compuestos de tipo oxatiazina |
-
2015
- 2015-12-17 ES ES15821172T patent/ES2907592T3/es active Active
- 2015-12-17 EP EP21211288.2A patent/EP4011871A3/en active Pending
- 2015-12-17 MX MX2019013194A patent/MX392353B/es unknown
- 2015-12-17 WO PCT/IB2015/059741 patent/WO2016098054A1/en not_active Ceased
- 2015-12-17 SM SM20220091T patent/SMT202200091T1/it unknown
- 2015-12-17 US US15/535,266 patent/US10392355B2/en active Active
- 2015-12-17 PT PT158211722T patent/PT3233813T/pt unknown
- 2015-12-17 CA CA2971570A patent/CA2971570A1/en active Pending
- 2015-12-17 KR KR1020177019296A patent/KR102594322B1/ko active Active
- 2015-12-17 EP EP15821172.2A patent/EP3233813B1/en active Active
- 2015-12-17 HU HUE15821172A patent/HUE058257T2/hu unknown
- 2015-12-17 RS RS20220195A patent/RS62955B1/sr unknown
- 2015-12-17 CN CN201580072835.0A patent/CN107257786B/zh active Active
- 2015-12-17 PL PL15821172T patent/PL3233813T3/pl unknown
- 2015-12-17 AU AU2015365348A patent/AU2015365348B2/en active Active
- 2015-12-17 HR HRP20220313TT patent/HRP20220313T1/hr unknown
- 2015-12-17 LT LTEPPCT/IB2015/059741T patent/LT3233813T/lt unknown
- 2015-12-17 CN CN202310038641.5A patent/CN119454714A/zh active Pending
- 2015-12-17 SI SI201531791T patent/SI3233813T1/sl unknown
- 2015-12-17 DK DK15821172.2T patent/DK3233813T3/da active
- 2015-12-17 MX MX2017008112A patent/MX369462B/es active IP Right Grant
- 2015-12-17 JP JP2017551388A patent/JP6746605B2/ja active Active
- 2015-12-17 CN CN201910974314.4A patent/CN110776479A/zh active Pending
-
2017
- 2017-06-14 IL IL252912A patent/IL252912B/en active IP Right Grant
-
2019
- 2019-08-12 US US16/538,344 patent/US10968190B2/en active Active
- 2019-11-05 AU AU2019261702A patent/AU2019261702B2/en active Active
- 2019-11-15 JP JP2019206621A patent/JP7030093B2/ja active Active
-
2021
- 2021-11-12 JP JP2021184435A patent/JP7449913B2/ja active Active
-
2022
- 2022-03-04 CY CY20221100186T patent/CY1125047T1/el unknown
-
2023
- 2023-11-30 JP JP2023202330A patent/JP7688098B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022031717A5 (enExample) | ||
| JP2018502909A5 (enExample) | ||
| WO2012147019A1 (en) | An improved process for the preparation of silodosin | |
| TWI758313B (zh) | 一種用於製備(1r,3r)-及(1s,3s)-2,2-二鹵基-3-(經取代之苯基)環丙烷甲酸的方法 | |
| EP2346850A1 (en) | A method for the preparation of dabigatran and its intermediates | |
| CN107141246B (zh) | 一种靛红衍生物的制备方法 | |
| JP7144873B2 (ja) | スガマデクスナトリウム塩の製造方法 | |
| JP2022060192A5 (enExample) | ||
| JP6228210B2 (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
| EA022300B1 (ru) | Разделение энантиомеров 2-амино-3,6-дигидро-4-диметиламино-6-метил-1,3,5-триазина с использованием винной кислоты | |
| CN103724248B (zh) | 维格列汀工艺杂质的制备方法 | |
| KR100881890B1 (ko) | 사포그렐레이트 염산염의 제조방법 | |
| JP6887022B2 (ja) | ケトライド化合物を製造するための方法 | |
| KR101686087B1 (ko) | 광학 활성을 갖는 인돌린 유도체 또는 이의 염의 신규 제조 방법 | |
| CN107056653B (zh) | 布南色林中间体对氟苯甲酰乙腈的合成方法 | |
| CN117402144B (zh) | 一种3cl蛋白酶抑制剂的制备方法 | |
| CN102757414A (zh) | 艾司西酞普兰草酸盐的制备方法 | |
| CN111635368B (zh) | 一种胺化合物的制备方法 | |
| EP2488516A2 (en) | Process for the preparation of lamivudine and novel salts in the manufacture thereof | |
| JP4528884B2 (ja) | ゲムシタビンの合成に有用なナフタレン−２−カルボキシレート誘導体及びその製造方法 | |
| JPWO2003057665A1 (ja) | ベンゼンスルホンアミド誘導体結晶の製造方法、およびその中間体の新規結晶とその製造方法 | |
| CN1489575A (zh) | 苯甲脒衍生物及其制备方法 | |
| CN120607527A (zh) | 一种以碳酸二甲酯为酰化试剂的维立西呱制备方法 | |
| JP3682291B2 (ja) | オレアノール酸誘導体の製造方法 | |
| CN106928139B (zh) | 一种贝达喹啉杂质的合成方法 |